Liontrust Investment Partners LLP discloses 4.9% stake in Maxcyte
Maxcyte
- 4.9%[1]
Liontrust Investment Partners LLP reported a 4.9% stake in Maxcyte (MXCT) in a Schedule 13D filed with the SEC on Nov 2, 2026. The filing covers 5,081,403 shares and cuts its earlier 5% stake.[1]
| Reporting person | Security | Shares | Ownership | Filed |
|---|---|---|---|---|
| Liontrust Investment Partners LLP | Maxcyte, Inc | 5,081,403 | 4.9% | 2026-11-02 |
What is a Schedule 13D?
A Schedule 13D can signal intent to influence a company. Holders above five percent of a class must file one. It reports ownership, not a trade price.[1]
How did the stake change?
Liontrust Investment Partners LLP reported 5% in its earlier filing and 4.9% now.[1]
What does this filing not show?
The form shows ownership on its cover page. It does not show what the holder paid or what it plans to do next.[1]
